H.R. 2069 · 114th Congress
Neuromyelitis Optica Consortium Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 114th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
LeeSponsorNo cosponsors.
This bill amends the Public Health Service Act to require the National Institutes of Health to establish, administer, and coordinate a National Neuromyelitis Optica (NMO) Consortium to:
What it does: CRS summary · Introduced in House · Apr 28, 2015
Neuromyelitis Optica Consortium Act
This bill amends the Public Health Service Act to require the National Institutes of Health to establish, administer, and coordinate a National Neuromyelitis Optica (NMO) Consortium to:
- award grants for research on the causes of, and the risk factors and biomarkers associated with, NMO (a neurological disease leading to blindness and paralysis);
- assemble a panel of experts to provide ongoing guidance and recommendations on research design and protocols; and
- designate a central laboratory to collect, analyze, and aggregate data from this research and to make the data and analysis available to researchers.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Neuromyelitis Optica Consortium Act
Latest action (May 1, 2015): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Apr 28, 2015
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.